BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32701670)

  • 1. Obstructive sleep apnea in pulmonary fibrosis.
    Schiza SE; Bouloukaki I; Bolaki M; Antoniou KM
    Curr Opin Pulm Med; 2020 Sep; 26(5):443-448. PubMed ID: 32701670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis.
    Mermigkis C; Bouloukaki I; Schiza SE
    Chest; 2017 Dec; 152(6):1327-1338. PubMed ID: 28774636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Description of the Hyperpnea-Hypopnea Periodic Breathing in Patients with Interstitial Lung Disease-Obstructive Sleep Apnea: Treatment Implications in a Real-Life Setting.
    Canora A; Nicoletta C; Ghinassi G; Bruzzese D; Rea G; Capaccio A; Castaldo S; Coppola A; Polistina GE; Sanduzzi A; Bocchino M
    Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31779226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstructive sleep apnea in patients with interstitial lung disease: Prevalence and predictive factors.
    Lee JH; Park CS; Song JW
    PLoS One; 2020; 15(10):e0239963. PubMed ID: 33017401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical impacts of obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: A single-center, retrospective study.
    Lee JH; Jang JH; Park JH; Lee S; Kim JY; Ko J; Jung SY; Kim DW; Hong S; Jang HJ
    PLoS One; 2023; 18(9):e0291195. PubMed ID: 37751461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of obstructive sleep apnea in idiopathic pulmonary fibrosis.
    Wang TC; Shen TC; Lin CL; Hsu CY
    Eur J Intern Med; 2023 Apr; 110():120-121. PubMed ID: 36564241
    [No Abstract]   [Full Text] [Related]  

  • 7. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
    Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
    Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis.
    Gille T; Didier M; Boubaya M; Moya L; Sutton A; Carton Z; Baran-Marszak F; Sadoun-Danino D; Israël-Biet D; Cottin V; Gagnadoux F; Crestani B; d'Ortho MP; Brillet PY; Valeyre D; Nunes H; Planès C;
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28596432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.
    Schiza S; Mermigkis C; Margaritopoulos GA; Daniil Z; Harari S; Poletti V; Renzoni EA; Torre O; Visca D; Bouloukaki I; Sourvinos G; Antoniou KM
    Eur Respir Rev; 2015 Jun; 24(136):327-39. PubMed ID: 26028644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing complications and co-morbidities of fibrotic interstitial lung disease.
    Margaritopoulos GA; Kokosi MA; Wells AU
    Expert Rev Respir Med; 2019 Jul; 13(7):645-658. PubMed ID: 31215263
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and impact of comorbid obstructive sleep apnoea in diffuse parenchymal lung diseases.
    Li D; Wang B; Liu Y; Wang H
    PLoS One; 2021; 16(2):e0246878. PubMed ID: 33571266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OSA and Prolonged Oxygen Desaturation During Sleep are Strong Predictors of Poor Outcome in IPF.
    Bosi M; Milioli G; Fanfulla F; Tomassetti S; Ryu JH; Parrino L; Riccardi S; Melpignano A; Vaudano AE; Ravaglia C; Tantalocco P; Rossi A; Poletti V
    Lung; 2017 Oct; 195(5):643-651. PubMed ID: 28674777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of obstructive sleep apnoea in patients with fibrotic lung diseases.
    Pereira N; Cardoso AV; Mota PC; Santos AC; Melo N; Morais A; Drummond M
    Sleep Med; 2019 Apr; 56():123-127. PubMed ID: 30879993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung disease and obstructive sleep apnea.
    Khor YH; Ryerson CJ; Landry SA; Howard ME; Churchward TJ; Edwards BA; Hamilton GS; Joosten SA
    Sleep Med Rev; 2021 Aug; 58():101442. PubMed ID: 33561604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does gender matter: sex-specific aspects of symptoms, outcome, and therapy of obstructive sleep apnea.
    Schiza SE; Bouloukaki I
    Curr Opin Pulm Med; 2020 Nov; 26(6):642-649. PubMed ID: 32890020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of obstructive sleep apnea in interstitial lung disease: a systematic review and meta-analysis.
    Cheng Y; Wang Y; Dai L
    Sleep Breath; 2021 Sep; 25(3):1219-1228. PubMed ID: 33403599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease.
    Troy LK; Young IH; Lau EMT; Wong KKH; Yee BJ; Torzillo PJ; Corte TJ
    Respirology; 2019 Oct; 24(10):996-1004. PubMed ID: 30933419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep and respiratory sleep disorders in idiopathic pulmonary fibrosis.
    Milioli G; Bosi M; Poletti V; Tomassetti S; Grassi A; Riccardi S; Terzano MG; Parrino L
    Sleep Med Rev; 2016 Apr; 26():57-63. PubMed ID: 26168886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of moderate to severe obstructive sleep apnea on the cognition in idiopathic pulmonary fibrosis.
    Tudorache V; Traila D; Marc M; Oancea C; Manolescu D; Tudorache E; Timar B; Albai A; Fira-Mladinescu O
    PLoS One; 2019; 14(2):e0211455. PubMed ID: 30707735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease.
    Pillai M; Olson AL; Huie TJ; Solomon JJ; Fernandez-Perez ER; Brown KK; Hanna P; Lee-Chiong T; Swigris JJ
    Respir Med; 2012 Jul; 106(7):1033-9. PubMed ID: 22521226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.